Anatara’s greater prospects lie with human health, as a remedy for the common but difficult-to-treat afflictions of irritable bowel syndrome and inflammatory bowel disease(ulcerative colitis and Crohn’s disease).
Mr Lydeamore notes that gut health is “very topical”, which is an understatement given the range of digestion-related ‘wellness’ products purveyed by the likes of Blackmores and Suisse. “If you do a Google search on the topic you will get more than 400 million hits,” he says.
He’s right: your columnist’s rigorous cross-checking of this claim reveals 530 million online references.
For the full article, please click here –
Dr Boreham’s Crucible – Anatara Lifesciences